Unitronix Corporation (UTRX)
USD 0.07
(18.18%)
USD 0.07
(18.18%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2004 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | 4630.00 | - | 114.13 Thousand |
| Cost of Revenue | - | - | - | - | - | 79.87 Thousand |
| Gross Profit | - | - | - | 4630.00 | - | 34.26 Thousand |
| Operating Expenses | 170.81 Thousand | 177.02 Thousand | 73.08 Thousand | 74.89 Thousand | - | 124.48 Thousand |
| Selling, General and Administrative Expenses | 170.81 Thousand | 164.28 Thousand | 68 Thousand | 74.89 Thousand | - | 124.48 Thousand |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | 72.8 Thousand | 172.00 | - | - | - |
| Cost and Expenses | 170.81 Thousand | 177.02 Thousand | 73.08 Thousand | 74.89 Thousand | - | 204.35 Thousand |
| Operating Income | -170.81 Thousand | -187.91 Thousand | -73.3 Thousand | -70.26 Thousand | - | 90.21 Thousand |
| Interest Expense | 32.04 Thousand | 9012.00 | - | - | - | 98.46 Thousand |
| Income Tax Expense | - | -12.68 Thousand | -236.38 Thousand | -206.29 Thousand | - | -180.43 Thousand |
| Earnings before Tax | -307.69 Thousand | -102.43 Thousand | -73.13 Thousand | -70.26 Thousand | - | -188.68 Thousand |
| Net Income | -307.69 Thousand | -102.43 Thousand | -73.13 Thousand | -70.26 Thousand | - | -188.68 Thousand |
| Earnings Per Share Basic | -0.00 | -0.00 | -0.00 | -0.00 | - | -0.02 |
| Earnings Per Share Diluted | -0.00 | -0.00 | -0.00 | -0.00 | - | -0.02 |
| Weighted Average Shares Outstanding | 207.5 Million | 207.5 Million | 29.67 Million | 29.67 Million | 29.67 Million | 9.85 Million |
| Weighted Average Shares Outstanding (Diluted) | 207.5 Million | 207.5 Million | 29.67 Million | 29.67 Million | 29.67 Million | 9.85 Million |
| Gross Margin | - | - | - | 1.00 | - | 0.30 |
| EBIT Margin | - | - | - | -15.17 | - | -0.79 |
| Profit Margin | - | - | - | -15.18 | - | -1.65 |
| EBITDA | -275.66 Thousand | -93.42 Thousand | -73.13 Thousand | -70.26 Thousand | - | -90.11 Thousand |
| Earnings Before Tax Margin | - | - | - | -15.17 | - | 0.79 |
| Breakdown | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| Operating Expenses | 62.58 Thousand | 36.06 Thousand | 36.52 Thousand | 35.64 Thousand | 177.02 Thousand | 37.71 Thousand |
| Selling, General and Administrative Expenses | 62.58 Thousand | 36.06 Thousand | 36.52 Thousand | 34.67 Thousand | - | 37.71 Thousand |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | - | - | - | 72.8 Thousand | - |
| Cost and Expenses | 62.58 Thousand | 36.06 Thousand | 36.52 Thousand | 35.64 Thousand | 177.02 Thousand | 37.71 Thousand |
| Operating Income | -62.58 Thousand | -36.06 Thousand | -36.52 Thousand | -27.68 Thousand | -187.91 Thousand | -37.72 Thousand |
| Interest Expense | 13.62 Thousand | 105.00 | 8770.00 | 9547.00 | 9012.00 | 10.89 Thousand |
| Income Tax Expense | - | 39.58 Thousand | -122.08 Thousand | 1.00 | -12.68 Thousand | -54.88 Thousand |
| Earnings before Tax | -89.02 Thousand | -139.88 Thousand | -41.56 Thousand | -37.22 Thousand | -102.43 Thousand | -26.78 Thousand |
| Net Income | -89.02 Thousand | -139.88 Thousand | -41.56 Thousand | -37.22 Thousand | -102.43 Thousand | -26.78 Thousand |
| Earnings Per Share Basic | -0.00 | -0.00 | -0.00 | -0.00 | - | -0.00 |
| Earnings Per Share Diluted | -0.00 | -0.00 | -0.00 | -0.00 | - | -0.00 |
| Weighted Average Shares Outstanding | 207.5 Million | 207.5 Million | 207.5 Million | 207.5 Million | 207.5 Million | 207.5 Million |
| Weighted Average Shares Outstanding (Diluted) | 207.5 Million | 207.5 Million | 207.5 Million | 207.5 Million | 207.5 Million | 207.5 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -80.04 Thousand | -36.06 Thousand | -36.52 Thousand | -27.68 Thousand | - | -37.72 Thousand |
| Earnings Before Tax Margin | - | - | - | - | - | - |
ITOS
CRR-UN
FRLOF
ORBTEXP
3DA
AGY